rs1245810
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005639.3(SYT1):c.166+25930A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.701 in 151,974 control chromosomes in the GnomAD database, including 37,792 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.70 ( 37792 hom., cov: 31)
Consequence
SYT1
NM_005639.3 intron
NM_005639.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.188
Publications
6 publications found
Genes affected
SYT1 (HGNC:11509): (synaptotagmin 1) This gene encodes a member of the synaptotagmin protein family. The synaptotagmins are integral membrane proteins of synaptic vesicles that serve as calcium sensors in the process of vesicular trafficking and exocytosis. The encoded protein participates in triggering neurotransmitter release at the synapse in response to calcium binding. Mutations in this gene are associated with Baker-Gordon syndrome. [provided by RefSeq, Jan 2023]
SYT1 Gene-Disease associations (from GenCC):
- infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.753 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SYT1 | NM_005639.3 | c.166+25930A>C | intron_variant | Intron 4 of 10 | ENST00000261205.9 | NP_005630.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.701 AC: 106481AN: 151856Hom.: 37775 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
106481
AN:
151856
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.701 AC: 106530AN: 151974Hom.: 37792 Cov.: 31 AF XY: 0.697 AC XY: 51776AN XY: 74264 show subpopulations
GnomAD4 genome
AF:
AC:
106530
AN:
151974
Hom.:
Cov.:
31
AF XY:
AC XY:
51776
AN XY:
74264
show subpopulations
African (AFR)
AF:
AC:
31510
AN:
41444
American (AMR)
AF:
AC:
11077
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2166
AN:
3468
East Asian (EAS)
AF:
AC:
2229
AN:
5152
South Asian (SAS)
AF:
AC:
2498
AN:
4812
European-Finnish (FIN)
AF:
AC:
7756
AN:
10538
Middle Eastern (MID)
AF:
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
AC:
46897
AN:
67972
Other (OTH)
AF:
AC:
1427
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1579
3158
4736
6315
7894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1684
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.